[1]
“In silico evaluation of the inhibitory effect of antiretrovirals Atazanavir and Darunavir on the main protease of SARS-CoV-2: docking studies and molecular dynamics”, RSD, vol. 9, no. 8, p. e826986562, Jul. 2020, doi: 10.33448/rsd-v9i8.6562.